Non-Insulin Antidiabetics & Duration of Follow-Up and Duration of Use

Basic Details
Status
Complete
Last Updated
Tuesday, April 2, 2019
Health Outcome(s)
duration of follow-up
duration of use
Purpose
Methods and Development
Regulatory Determination / Use

Feasibility assessment that supported an ARIA sufficiency determination to replace a sponsor postmarketing requirement (PMR) safety study for canagliflozin and renal cell carcinoma.